Showing 31-40 of 229 results for "".
First, Do No Harm
https://practicaldermatology.com/conferences/scale-2023/first-do-no-harm/20206/Joel L. Cohen, MD, and Mathew M. Avram, MD, JD, discuss why dermatologists should report any side effects to the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database.Evaluating GEP Test Options
https://practicaldermatology.com/programs/practical-dermatology/evaluating-gep-test-options/35600/David Cotter, MD, a board-certified dermatologist, discusses what he looks for in a gene expression profile (GEP) test, including the types of clinical evidence that are most important.It's All About the Fundamentals
https://practicaldermatology.com/conferences/aad-summer-2021/its-all-about-the-fundamentals/19972/Just like in athletics, mastering fundamentals is also key to success when it comes to running the business side of your practice. Shani Francis, MD, MBA says understanding business basics allows dermatologists to make informed, educated decisions, which is especially important as practices have hadWhat Are You Looking Forward to at SDDS?
https://practicaldermatology.com/topics/practice-management/what-are-you-looking-forward-to-at-sdds/19717/Sarah Lonowski, MD, MBA, Division of Dermatology, University of California Los Angeles, Los Angeles talks about what she hopes to learn at the inaugural SDDS in May. UPDATE: The inaugural 2020 San Diego Dermatology Symposium will be held September 11-13, 2020 at the InterContinental San Diego: sddeNew Drug Developments in Dermatology
https://practicaldermatology.com/topics/skin-cancer-photoprotection/new-drug-developments-in-dermatology/19971/Despite the COVID pandemic, the FDA had a nearly record year in drug approvals, says Vinod Nambudiri, MD, MBA, which has translated to new developments in dermatology. He discusses approvals of tirbanibulin 1% ointment for actinic keratoses and clascoterone cream 1% for acne, and how they fit into tFillers and Cosmetic Procedures
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/fillers-and-cosmetic-procedures/19367/Hayes B. Gladstone, MD discusses emerging options in the field of cosmetic dermatology, including new devices and injectables.Skin Reactions: Understanding New Drug Adverse Effects
https://practicaldermatology.com/conferences/aad-summer-2021/skin-reactions-understanding-new-drug-adverse-effects/19975/In addition to needing to stay abreast of new drugs in dermatology, it's important for dermatologists to stay informed about new medications that come to market in general. Vinod Nambudiri, MD, MBA says there are often dermatology-related adverse events that need to be managed. He discusses new cancScientifically Speaking: Updated Approaches to Surgical/Aesthetic Patient Safety
https://practicaldermatology.com/series/scientifically-speaking/scientifically-speaking-updated-approaches-to-surgicalaesthetic-patient-safety/19905/From antiseptics to eye shields, a panel of experts weighs in what you should be doing in your surgical and aesthetic practice to support patient and physician safety. Host Joel L. Cohen, MD leads the conversation with Mathew Avram, MD, JD; Brian Biesman, MD; Suzanne Kilmer, MD; and Christopher ZachDefining the Physician-Patient Relationship
https://practicaldermatology.com/topics/practice-management/defining-the-physician-patient-relationship/18928/In this edition of Derm Insider, Allan Wirtzer, MD and Cliff Lober, MD, JD talk to host Neal Bhatia, MD about the importance of defining the physician-patient relationship, determining when the relationship is established, and understanding the legal implications that come with that fiduciary or heiScientifically Speaking: When Accidents Happen in the Surgical/Aesthetic Clinic
https://practicaldermatology.com/topics/practice-management/scientifically-speaking-when-accidents-happen-in-the-surgicalaesthetic-clinic/19906/Surgical and laser procedures bring risks for infections, ocular injury, scarring, and more. In the second of a 2-part series, experts discuss best practices for managing adverse reactions with an emphasis on early intervention. Host Joel L. Cohen, MD leads the conversation with Mathew Avram, MD, JD